Thiotepa Riemser
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Thiotepa Riemser, covering 2023-10-23 to 2026-08-06. Get the full timeline:
Most recent: EMA Authorised: Thiotepa Riemser (thiotepa) — Esteve Pharmaceuticals GmbH